Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
15.11
+0.08 (0.53%)
Sep 10, 2026, 1:08 PM EDT - Market open
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $221.79 million as of September 10, 2026. Its market cap has increased by 47.92% in one year.
Market Cap
221.79M
Enterprise Value
212.91M
1-Year Change
47.92%
Ranking
Category
Stock Price
$15.11
ChartMarket Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $221.79M, an increase of 222.89%. That is a compound annual growth rate of 21.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 221.79M | -23.81% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 226.50M |
| Protara Therapeutics | 226.34M |
| Neumora Therapeutics | 225.48M |
| Veraxa Biotech AG | 224.84M |
| Keros Therapeutics | 224.25M |
| Cue Biopharma | 221.56M |
| Tonix Pharmaceuticals Holding | 220.05M |
| Adagene | 219.56M |